PACT Pharma is synthesizing neo-epitope targeted T cells and producing a personalized adoptive cell therapy designed to benefit each cancer patient.
Webinar Validation and Harmonization of Immunoprofiling Assays by PACT CIMAC CIDC
November 18, 2021
https://www.youtube.com/watch?v=faCs_hTREkY